32 results on '"Sahloff, Eric G."'
Search Results
2. Use of multiple pharmacies by people living with HIV
3. A Narrative Review of Novel Agents for Managing Heavily Treatment-Experienced People Living With HIV.
4. 327. Use of multiple pharmacies by people living with HIV: a qualitative analysis
5. The Role of Community Pharmacies in Providing Access to HIV Post-exposure Prophylaxis (PEP)
6. Personalizing Prevention: Advances in Pharmacotherapy for HIV Prevention
7. Is Long-acting Cabotegravir a Pre-exposure Prophylaxis Option for Women of Childbearing Potential?
8. A Standardized Rubric to Evaluate Student Presentations
9. Alternative antiretroviral therapy formulations for patients unable to swallow solid oral dosage forms
10. Health-Related Internet Use in an HIV-Infected Population
11. Maraviroc: A coreceptor CCR5 antagonist for management of HIV infection
12. The activity of 14-hydroxy clarithromycin, alone and in combination with clarithromycin, against penicillin- and erythromycin-resistant Streptococcus pneumoniae
13. Use of an On-Site Outpatient Pharmacy for Acquisition of Antiretroviral Medications Compared to Off-Site Pharmacy Options: Impact on Retention in Care and Clinical Outcomes in People Living With HIV.
14. In vitro activity of ciprofloxacin, levofloxacin, sparfloxacin, and trovafloxacin alone or in combination with piperacillin, ceftazidime, and gentamicin against Alcaligenes xylosoxidans ssp. xylosoxidans.: 103E.
15. Use of an On-Site Outpatient Pharmacy for Acquisition of Antiretroviral Medications Compared to Off-Site Pharmacy Options: Impact on Retention in Care and Clinical Outcomes in People Living With HIV
16. Clinical Outcomes Associated With Once-Daily Ritonavir-Boosted Darunavir Plus Tenofovir/Emtricitabine in HIV-Infected Patients Harboring at Minimum a M184V/I Resistance Mutation
17. Evaluating the validity and reliability of a modified survey to assess patient satisfaction with mail-order and community pharmacy settings
18. Clinical Outcomes Associated With Once-Daily Ritonavir-Boosted Darunavir Plus Tenofovir/Emtricitabine in HIV-Infected Patients Harboring at Minimum a M184V/I Resistance Mutation.
19. Evaluation of Serum Creatinine Changes With Integrase Inhibitor Use in Human Immunodeficiency Virus-1 Infected Adults
20. Gingival Hypertrophy Associated with Amlodipine Use in an HIV-Infected Woman
21. Evaluating the Validity and Reliability of a Modified Survey to Assess Patient Satisfaction With Mail-Order and Community Pharmacy Settings
22. Exogenous Cushing Syndrome with Inhaled Fluticasone in a Child Receiving Lopinavir/Ritonavir
23. Clinical Outcomes Associated with Concomitant Use of Atazanavir and Proton Pump Inhibitors
24. Use of Highly Active Antiretroviral Therapy in Patients with Renal Insufficiency
25. CARBAPENEM ACTIVITY AGAINST ACINETOBACTER CALCOACETICUS-BAUMANII COMPLEX (AC) IN AN IN VITRO PHARMACOKINETIC MODEL(PKM)
26. SUBTLE IMIPENEM RESISTANCE IN AN ICU OUTBREAK OF ACINETOBACTER-BAUMANII CALCOACETICUS (ACBC)
27. Evaluation and cost assessment of fluoroquinolones in community-acquired respiratory infections
28. Fluoroquinolone E-Testing against Pseudomonas Aeruginosa and Streptococcus Pneumoniae
29. Extended-Spectrum β-Lactamase Resistance in the ICU
30. 1324. Successful Intervention to Reduce the Time Interval Between Diagnosis and Viral Load Suppression in Patients Living with HIV in the Midwestern United States.
31. Current Issues in the Development of a Vaccine to Prevent Human Immunodeficiency Virus.
32. Evaluation and cost assessment of fluoroquinolones in community-acquired respiratory infections.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.